Fatal malignant hyperthermia - Delayed onset and atypical course

Forensic Science International

Volumn 129, Issue 3, 2002, Pages 187-190

  Karger, B ^a   Teige, K ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

Author keywords

Anaesthesia; Autopsy; Histology; Malignant hyperthermia; Myoglobin clot

Indexed keywords

ISOFLURANE; MYOGLOBIN; SUXAMETHONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; AUTOPSY; BLOOD CLOTTING; BODY TEMPERATURE; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DEATH CERTIFICATE; DISEASE COURSE; EDEMA; END TIDAL CARBON DIOXIDE TENSION; FATALITY; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTUBATION; KIDNEY DISEASE; LUNG CAPILLARY; MALE; MALIGNANT HYPERTHERMIA; MALPRACTICE; MASSETER MUSCLE; MULTIPLE ORGAN FAILURE; MUSCLE DISEASE; MUSCLE NECROSIS; MUSCLE RIGIDITY; MUSCLE SPASM; ONSET AGE; PRIORITY JOURNAL; SEPSIS; SKELETAL MUSCLE; URINARY EXCRETION;

EID: 0037048629     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(02)00272-4     Document Type: Article

References (16)

1. Denborough M.A., Lovell R.R.H. Anaesthetic deaths in a family. Lancet. 2:1960;45.
2. Gronert G.A. Malignant hyperthermia. Anaesthesiology. 53:1980;395-423.
3. Ellis F.R., Halsall P.J., Christian A.S. Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands. Anaesthesia. 45:1990;838-841.
4. Urwyler A., Hartung E. Die maligne hyperthermie. Anaesthesist. 43:1994;557-569.
5. Hopkins P.M. Malignant hyperthermia: advances in clinical management and diagnosis. Br. J. Anaesth. 85:2000;118-128.
6. Reber A., Schumacher P., Urwyler A. Effects of three different types of management on the elimination kinetics of volatile anaesthetics - implications for malignant hyperthermia treatment. Anaesthesia. 48:1993;862-865.
7. Ranklev E., Fletcher R. Investigation of malignant hyperthermia in Sweden. Acta Anaesthesiol. Scand. 30:1986;693-696.
8. Hopkins P.M., Hartung E., Wappler F. The European Malignant Hyperthermia Group. Multicentre evaluation of ryanodine contracture testing in malignant hyperthermia. Br. J. Anaesth. 80:1998;389-393.
9. Maresch W. Maligne hyperthermie. Beitr. Gerichtl. Med. 30:1973;289-296.
10. Brinkmann B., Püschel K. Zur histomorphologie der herz- und skelettmuskulatur bei maligner hyperthermie. Z. Rechtsmed. 80:1977;117-133.
11. Püschel K., Brinkmann B. Tod durch maligne hyperthermie. Ätiologie, pathophysiologie, epidemiologie und pathomorphologie. Med. Welt. 29:1978;522-531.
12. Zhu B.L., Ishida K., Quan L., Taniguchi M., Oritani S., Kamikodai Y., Fujita M.Q., Maeda H. Postmortem urinary myoglobin levels with reference to the causes of death. Forensic Sci. Int. 115:2001;183-188.
13. Abe M., Saitoh H., Sato Y., Hamaguchi K., Kiuchi M. Immunohistochemical study of the kidneys after severe muscular injury. Int. J. Legal Med. 114:2001;232-236.
14. Allen G.C., Brubaker C.L. Human malignant hyperthermia associated with desflurane anaestesia. Anesth. Analg. 86:1998;1328-1331.
15. Britt B.A., Webb G.E., LeDuc C. Malignant hyperthermia induced by curare. Can. Anaesth. Soc. J. 21:1974;371-375.
16. Püschel K., Brinkmann B. Zum derzeitigen stand der bewertung des narkosezwischenfalls. "Maligne hyperthermie" aus forensisch-medizinischer sicht. Anaesthesist. 29:1980;99-102.